Literature DB >> 20046895

Simultaneous Quantification of Anandamide and Other Endocannabinoids in Dorsal Vagal Complex of Rat Brainstem by LC-MS.

Jing Chen1, Kalpana S Paudel, Andrei V Derbenev, Bret N Smith, Audra L Stinchcomb.   

Abstract

A quantitative method has been developed and validated for the simultaneous determination of anandamide (AEA), docosatetraenylethanolamide (DEA) and N-arachidonyldopamine (NADA) in dorsal vagal complex (DVC) of rat brainstem by liquid chromatographic-electrospray ionization mass spectrometry. The analytes were extracted from the tissue samples of rat brainstem by a single step liquid extraction technique using acetonitrile. The chromatographic separation was conducted on a C18 column using a gradient mobile phase consisting of methanol and water at a flow rate of 0.3 mL min(-1). The analytes were quantified by positive electrospray ionization mass spectrometry with selected ion monitoring (SIM) mode. The limits of detection (LOD) for AEA, DEA and NADA were 0.5, 1 and 0.5 ng mL(-1), respectively. This method required only simple processing of the samples and could be applied to monitor the change in the level of these compounds in DVC of the rat brain tissue. Time dependent (10-70 min) accumulation of the endocannabinoids (AEA, DEA, and NADA) in brain tissue was also studied, which included a novel examination of the accumulation of DEA as a function of time in rat brain tissue after decapitation.

Entities:  

Year:  2009        PMID: 20046895      PMCID: PMC2772084          DOI: 10.1365/s10337-008-0841-x

Source DB:  PubMed          Journal:  Chromatographia        ISSN: 0009-5893            Impact factor:   2.044


  35 in total

1.  The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.

Authors:  L De Petrocellis; T Bisogno; M Maccarrone; J B Davis; A Finazzi-Agro; V Di Marzo
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 2.  Cannabinoid receptors as therapeutic targets.

Authors:  Ken Mackie
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

3.  Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue.

Authors:  K Kempe; F F Hsu; A Bohrer; J Turk
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

4.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

Review 5.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

6.  Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.

Authors:  Mauro Maccarrone; Silvia Rossi; Monica Bari; Valentina De Chiara; Filomena Fezza; Alessandra Musella; Valeria Gasperi; Chiara Prosperetti; Giorgio Bernardi; Alessandro Finazzi-Agrò; Benjamin F Cravatt; Diego Centonze
Journal:  Nat Neurosci       Date:  2008-01-20       Impact factor: 24.884

7.  Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain.

Authors:  M Palkovits; J Harvey-White; J Liu; Z S Kovacs; M Bobest; G Lovas; A G Bagó; G Kunos
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

8.  Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets.

Authors:  E R Partosoedarso; T P Abrahams; R T Scullion; J M Moerschbaecher; P J Hornby
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

9.  Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry.

Authors:  Philip J Kingsley; Lawrence J Marnett
Journal:  Anal Biochem       Date:  2003-03-01       Impact factor: 3.365

10.  An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.

Authors:  Susan M Huang; Tiziana Bisogno; Marcello Trevisani; Abdulmonem Al-Hayani; Luciano De Petrocellis; Filomena Fezza; Michele Tognetto; Timothy J Petros; Jocelyn F Krey; Constance J Chu; Jeffrey D Miller; Stephen N Davies; Pierangelo Geppetti; J Michael Walker; Vincenzo Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

View more
  5 in total

1.  Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.

Authors:  Ming-Hua Li; Katherine L Suchland; Susan L Ingram
Journal:  J Neurosci       Date:  2017-01-18       Impact factor: 6.167

2.  Anti-inflammatory ω-3 endocannabinoid epoxides.

Authors:  Daniel R McDougle; Josephine E Watson; Amr A Abdeen; Reheman Adili; Megan P Caputo; John E Krapf; Rodney W Johnson; Kristopher A Kilian; Michael Holinstat; Aditi Das
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-07       Impact factor: 11.205

3.  Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.

Authors:  Daniel J Liput; Eleftheria Tsakalozou; Dana C Hammell; Kalpana S Paudel; Kimberly Nixon; Audra L Stinchcomb
Journal:  J Pharm Anal       Date:  2014-08

4.  Peptide and lipid modulation of glutamatergic afferent synaptic transmission in the solitary tract nucleus.

Authors:  Michael C Andresen; Jessica A Fawley; Mackenzie E Hofmann
Journal:  Front Neurosci       Date:  2013-01-10       Impact factor: 4.677

5.  Dexamethasone rapidly increases GABA release in the dorsal motor nucleus of the vagus via retrograde messenger-mediated enhancement of TRPV1 activity.

Authors:  Andrei V Derbenev; Bret N Smith
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.